ANGIOCYCLIC
Cyclacel Limited
Application Filed: 2008-10-01
Trademark Application Details
IR CANCELLED; US REGISTRATION CANCELLED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79060247 |
| Registration Number | 3784899 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | H |
| Attorney Name | Diane Donnelly |
| Law Office Assigned | M60 |
| Employee Name | LOWRY, LEIGH A |
Timeline
| 2008-10-01 | Application Filed |
| 2010-02-16 | Published for Opposition |
| 2010-05-04 | Location: PUBLICATION AND ISSUE SECTION |
| 2010-05-04 | Trademark Registered |
| 2018-10-01 | Cancelled |
| 2018-10-01 | Status: Dead/Cancelled |
| 2019-05-03 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Cyclacel Limited |
| Address | Dundee Technopole James Lindsay Place; Dundee DD1 5JJ GB |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; BIOPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; CHEMICAL PREPARATIONS AND SUBSTANCES FOR PHARMACEUTICAL, BIOPHARMACEUTICAL AND MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; MEDICAL THERAPEUTIC DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2008-11-13 | 1 REPR M: |
| NEW APPLICATION ENTERED IN TRAM | 2008-11-14 | 2 NWAP I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2008-11-18 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2008-12-30 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2008-12-31 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2009-01-01 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2009-01-05 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2009-01-05 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2009-02-05 | 9 RFNT P: |
| PAPER RECEIVED | 2009-05-29 | 10 MAIL I:Incoming Correspondence |
| ASSIGNED TO LIE | 2009-06-01 | 11 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-06-05 | 12 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2009-06-05 | 13 ACEC I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2009-06-29 | 14 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2009-06-29 | 15 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2009-06-29 | 16 GNFN O:Outgoing Correspondence |
| PAPER RECEIVED | 2009-12-03 | 17 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-12-07 | 18 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2009-12-07 | 19 ACEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2010-01-08 | 20 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2010-01-12 | 21 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2010-01-13 | 22 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2010-02-16 | 23 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2010-02-16 | 24 NPUB E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2010-04-15 | 25 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2010-04-15 | 26 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2010-04-30 | 27 OPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2010-05-04 | 28 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2010-08-04 | 29 FICR P: |
| FINAL DISPOSITION PROCESSED | 2010-08-13 | 30 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2010-08-13 | 31 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2013-02-05 | 32 FINO P: |
| CANCELLED SECTION 71 | 2016-12-09 | 33 C71T O:Outgoing Correspondence |
| TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2017-08-09 | 34 INTR P: |
| INVALIDATION PROCESSED | 2017-08-15 | 35 INPC P: |
| TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2017-08-15 | 36 INTS P: |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2017-09-08 | 37 INNT P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2018-03-30 | 38 NREP P: |
| DEATH OF INTERNATIONAL REGISTRATION | 2019-05-02 | 39 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2019-05-02 | 40 DENC O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 